State of Wisconsin Investment Board’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

State of Wisconsin Investment Board’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-360,000	Closed	-$3.64M	–	2657
2022 Q4	$3.64M	Hold	360,000	–	–	0.01%	1105
2022 Q3	$3.57M	Buy	360,000 +228,642	+174%	+$2.26M	0.01%	1102
2022 Q2	$1.3M	Hold	131,358	–	–	﹤0.01%	1503
2022 Q1	$1.29M	Buy	131,358 +8,074	+7%	+$79.5K	﹤0.01%	1592
2021 Q4	$1.21M	Buy	+123,284	New	+$1.21M	﹤0.01%	1393

State of Wisconsin Investment Board's BIOT Position: Q1 2023 in Review

State of Wisconsin Investment Board sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 360,000 shares — an estimated $3.64M sold.

State of Wisconsin Investment Board first reported a position in BIOT in Q4 2021 and held it in 5 quarters. The position peaked at $3.64M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

State of Wisconsin Investment Board reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 360,000 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $3.64M.
State of Wisconsin Investment Board first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2021 and held it in 5 quarters.
State of Wisconsin Investment Board's Biotech Acquisition Company Class A Ordinary Shares position peaked at $3.64M in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2023, filed 15 May 2023.